IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,318,000 | +14.1% | 67,759 | -2.3% | 0.02% | +14.3% |
Q4 2017 | $1,155,000 | +125.6% | 69,373 | +175.3% | 0.01% | +133.3% |
Q3 2017 | $512,000 | +26.1% | 25,200 | 0.0% | 0.01% | +20.0% |
Q2 2017 | $406,000 | +27.3% | 25,200 | 0.0% | 0.01% | +25.0% |
Q1 2017 | $319,000 | -4.5% | 25,200 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $334,000 | -94.7% | 25,200 | -90.5% | 0.00% | -94.9% |
Q3 2016 | $6,284,000 | -11.6% | 265,128 | +7.4% | 0.08% | -16.0% |
Q2 2016 | $7,112,000 | -7.5% | 246,800 | +2.8% | 0.09% | -6.0% |
Q1 2016 | $7,685,000 | -39.8% | 240,000 | -19.7% | 0.10% | -38.7% |
Q4 2015 | $12,772,000 | +39.1% | 298,700 | +14.5% | 0.16% | +34.7% |
Q3 2015 | $9,183,000 | -31.7% | 260,800 | -10.9% | 0.12% | -24.4% |
Q2 2015 | $13,436,000 | -2.0% | 292,600 | 0.0% | 0.16% | +1.3% |
Q1 2015 | $13,714,000 | +34.9% | 292,600 | -8.8% | 0.16% | +37.4% |
Q4 2014 | $10,166,000 | +33.6% | 320,900 | 0.0% | 0.12% | +27.8% |
Q3 2014 | $7,609,000 | +1.4% | 320,900 | +28.3% | 0.09% | +3.4% |
Q2 2014 | $7,504,000 | +12.8% | 250,200 | -0.6% | 0.09% | +11.5% |
Q1 2014 | $6,650,000 | -2.6% | 251,700 | -7.3% | 0.08% | -1.3% |
Q4 2013 | $6,828,000 | +22.0% | 271,600 | -0.7% | 0.08% | +54.9% |
Q3 2013 | $5,597,000 | -10.0% | 273,400 | -12.4% | 0.05% | -13.6% |
Q2 2013 | $6,222,000 | – | 312,100 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |